All Archived Articles

  • Global Health Conversations Podcast Launches April 2023

    Global Health Conversations Podcast Launches April 2023

    I am excited to announce that the Global Health Conversations Podcast launches in April 2023. Please click here and subscribe to my monthly newsletter to be notified 🙂 Read more

  • What are Clinical Trials ?

    What are Clinical Trials ?

    If your aim is to gain a bare bones understanding of clinical trials in 5 minutes or less, this is for you. Here I will explain what clinical trials are, some basic history, changes that have been made to effectuate what are called the ‘best’ clinical trials. There will be a part two to this… Read more

  • Human Rights Council – 40th Regular Session

    Human Rights Council – 40th Regular Session

    The Office for the United Nations High Commission on Human Rights (OHCHR) Human Rights Council is still ongoing this week! As a teen, I recall taking time off class with my student newspaper press pass with some fellow, editor colleagues to attend HRC sessions. If you haven’t been following – including the few walkouts during… Read more

  • Life Cycle Management: An ‘Insider’s’ guide on how to make your drug last FOREVER $$$

    Life Cycle Management: An ‘Insider’s’ guide on how to make your drug last FOREVER $$$

    A CASE STUDY In the pharmaceutical and biotechnology industries, there is a critical point in dealing with your novel agent when it becomes vital to have a clear and cohesive strategy as to how to manage and optimize the life of said drug, agent or device! Namely, ahead of introduction to the market. So, just… Read more

  • Antimicrobial Resistance Series : Intro to AMR

    Antimicrobial Resistance Series : Intro to AMR

    The term antibiotic was first coined in 1941 by Selman Waksman to describe any small molecule made by a microbe that antagonizes the growth of other microbes. The antibiotic age occurred with the development of other agents such as tetracycline, streptomycin and chloramphenicol from soil bacteria; amongst others. Modern medicine received a lifeline when Sir… Read more

  • Why Investors in the Pharmaceutical Industry Should Start Investing in Diseases Affecting Poor Countries.

    Why Investors in the Pharmaceutical Industry Should Start Investing in Diseases Affecting Poor Countries.

    Let’s discuss why investors in the pharmaceutical industry should start investing in drugs, therapeutics and medical devices aimed at treating, managing and ameliorating diseases affecting middle income countries in particular and the ‘global south’ in general. Read more

%d bloggers like this:
%d bloggers like this: